Tumor size matters differently in pulmonary adenocarcinoma and squamous cell carcinoma

Lung Cancer

Volumn 67, Issue 3, 2010, Pages 296-300

  Lin, Pei Ying ^a   Chang, Yeun Chung ^a   Chen, Hsuan Yu ^b   Chen, Chen Hao ^c   Tsui, Hung Chang ^c   Yang, Pan Chyr ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adenocarcinoma; Nodal distant metastases; Non small cell lung cancer (NSCLC); Size; Squamous cell carcinoma

Indexed keywords

ADULT; ARTICLE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 75749096907     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.04.017     Document Type: Article

References (25)

1. Veeramachaneni N.K., Battafarano R.J., Meyers B.F., Zoole J.B., and Patterson G.A. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 33 (2008) 466-469
2. Flieder D.B., Port J.L., Korst R.J., Christos P.J., Levin M.A., Becker D.E., et al. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest 128 (2005) 2304-2308
3. Christian C., Erica S., and Morandi U. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer 54 (2006) 185-191
4. Henschke C.I., Yankelevitz D.F., and Miettinen O.S. International Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 166 (2006) 321-325
5. Mujoomdar A., Austin J.H., Malhotra R., Powell C.A., Pearson G.D., Shiau M.C., et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 242 (2007) 882-888
6. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., and Graziano S.L. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 42 (2003) 51-57
7. Padilla J., Calvo V., Peñalver J.C., Sales G., and Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 63 (1997) 324-326
8. Clinical tumor size prognosis in lung cancer. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Eur Respir J 14 (1999) 812-816
9. Groome P.A., Bolejack V., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2 (2007) 694-705
10. Chen K.Y., Chang C.H., Yu C.J., Kuo S.H., and Yang P.C. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer 103 (2005) 2566-2574
11. Kabat G.C. Recent developments in the epidemiology of lung cancer. Semin Surg Oncol 9 (1993) 73-79
12. Watkin S.W., Hayhurst G.K., and Green J.A. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86. Br J Cancer 61 (1990) 590-596
13. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
14. Toh C.K., Gao F., Lim W.T., Leong S.S., Fong K.W., Yap S.P., et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 24 (2006) 2245-2251
15. Wisnivesky J.P., Yankelevitz D., and Henschke C.I. Stage of lung cancer in relation to its size: part 2. Evidence. Chest 127 (2005) 1136-1139
16. Fokas E., Engenhart-Cabillic R., Daniilidis K., Rose F., and An H.X. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 26 (2007) 705-715
17. Bajard A., Westeel V., Dubiez A., Jacoulet P., Pernet D., Dalphin J.C., et al. Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma. Lung Cancer 45 (2004) 317-323
18. Cox J.D., and Yesner R.A. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis 120 (1979) 1025-1029
19. Figlin R.A., Piantadosi S., and Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 318 (1988) 1300-1305
20. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
21. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
22. Molina J.R., Yang P., Cassivi S.D., Schild S.E., and Adjei A.A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83 (2008) 584-594
23. Toh C.K. The changing epidemiology of lung cancer. Methods Mol Biol 472 (2009) 397-411
24. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 21 (1999) 1194-1210
25. Subramanian J., and Govindan R. Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol 9 (2008) 676-682